Login to Your Account


DUBLIN – The twin phenomena of protein aggregation and deposition have been viewed almost exclusively through a pathology lens. The amyloid hypothesis in Alzheimer's disease – still not conclusively proven in clinical settings but by no means refuted either – is the most prominent example in human biology.

PERTH, Australia – Unlike its Australian peers, regenerative medicine company Regeneus Ltd. is not focusing on the U.S. market. Instead, it's placing its bets on Japan first and then will move out to other territories.

Mavupharma Inc., a new company developing therapies for cancer and infectious diseases, recently secured a $20 million series A financing led by Frazier Healthcare Partners, joined by Alpine Bioventures.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: